Articles On Pharmaust (ASX:PAA)
| Title | Source | Codes | Date |
|---|---|---|---|
|
Epichem makes final loan repayment for new laboratory
PharmAust (ASX:PAA), a clinical-stage oncology company, has announced its Perth-based synthetic and medicinal chemistry subsidiary Epichem has paid off its debt liability for a major laboratory expansion undertaken in 2015. |
BiotechDispatch | PAA | 6 years ago |